HLA-A*30:01 and HLA-A*33:03 are the protective alleles while HLA-A*01:01 serves as the susceptible gene for cervical cancer patients in Xinjiang, China

Antzeko izenburuak

• Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics
  nork: Xu Zhang, et al.
  Argitaratua: (2023-09-01)
• HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.
  nork: Paloma Martín, et al.
  Argitaratua: (2015-01-01)
• HLA-A*33:01 as protective allele for severe dengue in a population of Filipino children.
  nork: Edelwisa Segubre Mercado, et al.
  Argitaratua: (2015-01-01)
• Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics
  nork: Yufei Wang, et al.
  Argitaratua: (2024-04-01)
• Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients
  nork: Mepur H. Ravindranath, et al.
  Argitaratua: (2022-03-01)